Market Wrap: Nifty and Sensex Tumble Nearly 1% Amid Bearish Sentiment

2 min read     Updated on 08 Dec 2025, 03:32 PM
scanx
Reviewed by
Suketu GScanX News Team
Overview

Indian stock markets closed in the red on December 8, with Nifty 50 down 0.96% at 25,934.50 and BSE Sensex falling 0.84% to 84,989.45. Market breadth was overwhelmingly negative, with 3,656 stocks declining out of 4,694 traded. Despite the downturn, buzzing stocks included IndiGo facing government criticism, Biocon receiving FDA approval, Emmvee Photovoltaic's subsidiary deals, Adani Enterprises' green data centre plans, and HCLTech's chip development partnership.

26733761

*this image is generated using AI for illustrative purposes only.

Market Overview

The Indian stock markets closed in the red on December 8, 2025, with both benchmark indices witnessing significant declines. The Nifty 50 and BSE Sensex faced selling pressure throughout the session, resulting in a bearish close for the day.

Key Market Indicators

Index Closing Price Change % Change
Nifty 50 25,934.50 -251.95 -0.96%
BSE Sensex 84,989.45 -722.92 -0.84%

The Nifty 50 settled at 25,934.50, down 251.95 points or 0.96% from its previous close. Similarly, the BSE Sensex closed at 84,989.45, registering a decline of 722.92 points or 0.84%.

Market Breadth

The overall market breadth was decidedly negative, indicating widespread selling pressure across the board.

Category Number of Scrips
Total Traded 4,694
Positive 1,038
Negative 3,656

Out of the total 4,694 scrips traded, only 1,038 advanced while a substantial 3,656 declined, clearly reflecting the bearish sentiment in the market.

Buzzing Stocks

Several stocks made headlines due to significant corporate developments:

  1. IndiGo: The airline faced criticism from India's Aviation Minister for poor crew and roster management. The government announced plans for strict action against the company, potentially impacting its operations and stock performance.

  2. Biocon: The company received tentative FDA approval for its ANDA of Carbidopa and Levodopa extended-release capsules, used in treating Parkinson's disease. This regulatory milestone could positively influence the company's market position in neurological treatments.

  3. Emmvee Photovoltaic Power: The company's subsidiary entered into a supply agreement for TOPCon crystalline silicon photovoltaic cells with a 4.5GWp contracted offtake. Additionally, it completed a payment of Rs. 211.58 crore for land acquisition to develop a 6GW solar facility in Bengaluru.

  4. Adani Enterprises: The group announced plans to invest ₹25 billion in a green data centre project in Telangana. Furthermore, it incorporated a new subsidiary, Adani Airport City Limited, focusing on airport land development.

  5. HCLTech: The company formed a strategic partnership with Dolphin Semiconductor to co-develop energy-efficient chips, aiming to deliver scalable, high-efficiency system-on-chip solutions for IoT devices and data center applications.

Conclusion

The Indian stock market witnessed a significant downturn on December 8, 2025, with both the Nifty 50 and BSE Sensex closing nearly 1% lower. The negative market breadth, with over 77% of traded scrips declining, underscores the prevailing bearish sentiment. Despite the overall market decline, several individual stocks saw notable developments that could influence their future performance.

like17
dislike
Explore Other Articles